An Intact Raf Zinc Finger is Required for Optimal Binding to Processed Ras and for Ras-dependent Raf Activation in Situ

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 1997 Jan 1

PMID 8972184

Citations 40

Authors

Z Luo

B Diaz

M S Marshall

J Avruch

Affiliations

Soon will be listed here.

Abstract

The function of the c-Raf-1 zinc finger domain in the activation of the Raf kinase was examined by the creation of variant zinc finger structures. Mutation of Raf Cys 165 and Cys 168 to Ser strongly inhibits the Ras-dependent activation of c-Raf-1 by epidermal growth factor (EGF). Deletion of the Raf zinc finger and replacement with a homologous zinc finger from protein kinase C gamma (PKC gamma) (to give gamma/Raf) also abrogates EGF-induced activation but enables a vigorous phorbol myristate acetate (PMA)-induced activation. PMA activation of gamma/Raf does not require endogenous Ras or PKCs and probably occurs through a PMA-induced recruitment of gamma/Raf to the plasma membrane. The impaired ability of EGF to activate the Raf zinc finger variants in situ is attributable, at least in part, to a major decrement in their binding to Ras-GTP; both Raf zinc finger variants exhibit decreased association with Ras (V12) in situ upon coexpression in COS cells, as well as diminished binding in vitro to immobilized, processed COS recombinant Ras(V12)-GTP. In contrast, Raf binding to unprocessed COS or prokaryotic recombinant Ras-GTP is unaffected by Raf zinc finger mutation. Thus, the Raf zinc finger contributes an important component to the overall binding to Ras-GTP in situ, through an interaction between the zinc finger and an epitope on Ras, distinct from the effector loop, that is present only on prenylated Ras.

Citing Articles

An updated literature on BRAF inhibitors (2018-2023).

Maji L, Teli G, Raghavendra N, Sengupta S, Pal R, Ghara A Mol Divers. 2023; 28(4):2689-2730.

PMID: 37470921 DOI: 10.1007/s11030-023-10699-3.

RAS-targeted cancer therapy: Advances in drugging specific mutations.

Liu C, Ye D, Yang H, Chen X, Su Z, Li X MedComm (2020). 2023; 4(3):e285.

PMID: 37250144 PMC: 10225044. DOI: 10.1002/mco2.285.

Discovery of Raf Family Is a Milestone in Deciphering the Ras-Mediated Intracellular Signaling Pathway.

Zhao J, Luo Z Int J Mol Sci. 2022; 23(9).

PMID: 35563547 PMC: 9101324. DOI: 10.3390/ijms23095158.

Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers.

Dillon M, Lopez A, Lin E, Sales D, Perets R, Jain P Cancers (Basel). 2021; 13(20).

PMID: 34680208 PMC: 8534156. DOI: 10.3390/cancers13205059.

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy.

Degirmenci U, Wang M, Hu J Cells. 2020; 9(1).

PMID: 31941155 PMC: 7017232. DOI: 10.3390/cells9010198.

References

Kyriakis J, App H, Zhang X, Banerjee P, Brautigan D, Rapp U . Raf-1 activates MAP kinase-kinase. Nature. 1992; 358(6385):417-21. DOI: 10.1038/358417a0. View

Cadwallader K, PATERSON H, Macdonald S, Hancock J . N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization. Mol Cell Biol. 1994; 14(7):4722-30. PMC: 358845. DOI: 10.1128/mcb.14.7.4722-4730.1994. View

Howe L, Leevers S, Gomez N, Nakielny S, Cohen P, Marshall C . Activation of the MAP kinase pathway by the protein kinase raf. Cell. 1992; 71(2):335-42. DOI: 10.1016/0092-8674(92)90361-f. View

Zhang X, Settleman J, Kyriakis J, Elledge S, Marshall M, Bruder J . Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature. 1993; 364(6435):308-13. DOI: 10.1038/364308a0. View

Warne P, Viciana P, Downward J . Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature. 1993; 364(6435):352-5. DOI: 10.1038/364352a0. View

Vojtek A, Hollenberg S, Cooper J . Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell. 1993; 74(1):205-14. DOI: 10.1016/0092-8674(93)90307-c. View

Kyriakis J, Force T, Rapp U, Bonventre J, Avruch J . Mitogen regulation of c-Raf-1 protein kinase activity toward mitogen-activated protein kinase-kinase. J Biol Chem. 1993; 268(21):16009-19. View

Marshall M . The effector interactions of p21ras. Trends Biochem Sci. 1993; 18(7):250-4. DOI: 10.1016/0968-0004(93)90175-m. View

Troppmair J, Bruder J, Munoz H, Lloyd P, Kyriakis J, Banerjee P . Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J Biol Chem. 1994; 269(9):7030-5. View

10.

Ghosh S, Xie W, Quest A, Mabrouk G, Strum J, Bell R . The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras. J Biol Chem. 1994; 269(13):10000-7. View

11.

Kazanietz M, Bustelo X, Barbacid M, Kolch W, Mischak H, Wong G . Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products. J Biol Chem. 1994; 269(15):11590-4. View

12.

Chuang E, Barnard D, Hettich L, Zhang X, Avruch J, Marshall M . Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues. Mol Cell Biol. 1994; 14(8):5318-25. PMC: 359051. DOI: 10.1128/mcb.14.8.5318-5325.1994. View

13.

Avruch J, Zhang X, Kyriakis J . Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci. 1994; 19(7):279-83. DOI: 10.1016/0968-0004(94)90005-1. View

14.

Fridman M, Tikoo A, Varga M, Murphy A, Maruta H . The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype. J Biol Chem. 1994; 269(48):30105-8. View

15.

Ghosh S, Bell R . Identification of discrete segments of human Raf-1 kinase critical for high affinity binding to Ha-Ras. J Biol Chem. 1994; 269(49):30785-8. View

16.

Kuroda S, Shimizu K, Yamamori B, Matsuda S, Imazumi K, Kaibuchi K . Purification and characterization of REKS from Xenopus eggs. Identification of REKS as a Ras-dependent mitogen-activated protein kinase kinase kinase. J Biol Chem. 1995; 270(6):2460-5. DOI: 10.1074/jbc.270.6.2460. View

17.

Herrmann C, Martin G, Wittinghofer A . Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase. J Biol Chem. 1995; 270(7):2901-5. DOI: 10.1074/jbc.270.7.2901. View

18.

Brtva T, Drugan J, Ghosh S, Terrell R, Bell R, Der C . Two distinct Raf domains mediate interaction with Ras. J Biol Chem. 1995; 270(17):9809-12. DOI: 10.1074/jbc.270.17.9809. View

19.

Barnard D, Diaz B, Hettich L, Chuang E, Zhang X, Avruch J . Identification of the sites of interaction between c-Raf-1 and Ras-GTP. Oncogene. 1995; 10(7):1283-90. View

20.

Yamamori B, Kuroda S, Shimizu K, Fukui K, Ohtsuka T, Takai Y . Purification of a Ras-dependent mitogen-activated protein kinase kinase kinase from bovine brain cytosol and its identification as a complex of B-Raf and 14-3-3 proteins. J Biol Chem. 1995; 270(20):11723-6. DOI: 10.1074/jbc.270.20.11723. View